Annual Cash & Cash Equivalents
$68.44 M
-$2.17 M-3.08%
December 31, 2023
Summary
- As of February 7, 2025, OMGA annual cash & cash equivalents is $68.44 million, with the most recent change of -$2.17 million (-3.08%) on December 31, 2023.
- During the last 3 years, OMGA annual cash & cash equivalents has risen by +$45.49 million (+198.21%).
- OMGA annual cash & cash equivalents is now -63.30% below its all-time high of $186.48 million, reached on December 31, 2021.
Performance
OMGA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$30.38 M
-$15.47 M-33.75%
September 30, 2024
Summary
- As of February 7, 2025, OMGA quarterly cash and cash equivalents is $30.38 million, with the most recent change of -$15.47 million (-33.75%) on September 30, 2024.
- Over the past year, OMGA quarterly cash and cash equivalents has dropped by -$29.66 million (-49.40%).
- OMGA quarterly cash and cash equivalents is now -87.03% below its all-time high of $234.28 million, reached on September 30, 2021.
Performance
OMGA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
OMGA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.1% | -49.4% |
| 3 y3 years | +198.2% | -49.4% |
| 5 y5 years | +2909.8% | -49.4% |
OMGA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -63.3% | at low | -83.7% | at low |
| 5 y | 5-year | -63.3% | +2909.8% | -87.0% | +32.4% |
| alltime | all time | -63.3% | +2909.8% | -87.0% | +32.4% |
Omega Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $30.38 M(-33.7%) |
| Jun 2024 | - | $45.85 M(-23.6%) |
| Mar 2024 | - | $60.03 M(-12.3%) |
| Dec 2023 | $68.44 M(-3.1%) | $68.44 M(-16.3%) |
| Sep 2023 | - | $81.77 M(-22.5%) |
| Jun 2023 | - | $105.54 M(+1.0%) |
| Mar 2023 | - | $104.54 M(+48.0%) |
| Dec 2022 | $70.61 M | $70.61 M(-7.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $76.61 M(-15.7%) |
| Jun 2022 | - | $90.86 M(-14.0%) |
| Mar 2022 | - | $105.65 M(-43.3%) |
| Dec 2021 | $186.48 M(+712.5%) | $186.48 M(-20.4%) |
| Sep 2021 | - | $234.28 M(+91.4%) |
| Jun 2021 | - | $122.41 M(-11.1%) |
| Mar 2021 | - | $137.77 M(+500.3%) |
| Dec 2020 | $22.95 M(+909.3%) | $22.95 M |
| Dec 2019 | $2.27 M | - |
FAQ
- What is Omega Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Omega Therapeutics?
- What is Omega Therapeutics annual cash & cash equivalents year-on-year change?
- What is Omega Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Omega Therapeutics?
- What is Omega Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Omega Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of OMGA is $68.44 M
What is the all time high annual cash & cash equivalents for Omega Therapeutics?
Omega Therapeutics all-time high annual cash & cash equivalents is $186.48 M
What is Omega Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, OMGA annual cash & cash equivalents has changed by -$2.17 M (-3.08%)
What is Omega Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of OMGA is $30.38 M
What is the all time high quarterly cash and cash equivalents for Omega Therapeutics?
Omega Therapeutics all-time high quarterly cash and cash equivalents is $234.28 M
What is Omega Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, OMGA quarterly cash and cash equivalents has changed by -$29.66 M (-49.40%)